The increased levels of IL-6 in obesity may act as a compensatory mechanism to improve insulin resistance instead of inducing chronic low-grade inflammation (Pedersen and Febbraio, 2012). This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.